MLTX
#2307
MoonLake Immunotherapeutics - Class A Ordinary Shares
14.9 9 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-3.48%
Monthly Change
-18.71%
6 month change
-12.24%
Year Change
+56.80%
Previous Close
15.5 3
Open
14.9 8
Low
14.9 8
High
14.9 9
Volume
78
Financials
- Market Capitalization 1.28 B
- Employee 130
- Founded 2020
- CEO N/A
- Website www.moonlaketx.com
- Headquarter Cayman Islands
- FIGI BBG00XQZQTS9
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.73
Price to sales ratio
1 418.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2280 |  JBIO Jade Biosciences, Inc. - Common Stock | 20.84 USD | -2.11% | -2.02% | +6.93% | +107.36% | 1.33 B USD | ||
| 2302 |  DRTS Alpha Tau Medical Ltd. - Ordinary Shares | 14.64 USD | -1.15% | -1.94% | +28.31% | +330.59% | 1.29 B USD | ||
| 2311 |  MNKD MannKind Corporation - Common Stock | 3.95 USD | -2.71% | -4.59% | +1.28% | -25.47% | 1.27 B USD | ||
| 2312 |  IMTX Immatics N.V. - Ordinary Shares | 9.45 USD | +0.96% | +6.66% | +4.42% | -8.70% | 1.27 B USD |
Frequently asked questions about MoonLake Immunotherapeutics Class A Ordinary Shares
What is the MoonLake Immunotherapeutics Class A Ordinary Shares stock price today?
The current price of MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is 14.99. Over the past 24 hours, the stock has changed by -3.48%. Follow the MLTX chart for real-time price dynamics.
What is the stock ticker of MoonLake Immunotherapeutics Class A Ordinary Shares?
MoonLake Immunotherapeutics Class A Ordinary Shares trades under the ticker MLTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is MoonLake Immunotherapeutics Class A Ordinary Shares stock going up?
MLTX has changed by -4.40% over the last week, -18.71% over the last month, and +56.80% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of MoonLake Immunotherapeutics Class A Ordinary Shares?
MoonLake Immunotherapeutics Class A Ordinary Shares currently has a market capitalization of 1.28 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were MoonLake Immunotherapeutics Class A Ordinary Shares earnings last quarter?
Last quarter, MoonLake Immunotherapeutics Class A Ordinary Shares reported earnings of -0.84 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was MoonLake Immunotherapeutics Class A Ordinary Shares net income for the last quarter?
MoonLake Immunotherapeutics Class A Ordinary Shares reported net income of -61.8 M for the last quarter. The previous quarter showed -69.71 M, which means net income changed by +11.34%.
How many employees does MoonLake Immunotherapeutics Class A Ordinary Shares have?
As of the latest available data, MoonLake Immunotherapeutics Class A Ordinary Shares has 130 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy MoonLake Immunotherapeutics Class A Ordinary Shares stock?
You can buy MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in MoonLake Immunotherapeutics Class A Ordinary Shares stock?
Investing in MoonLake Immunotherapeutics Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MLTX chart and related analysis on metatrader.com as part of your research.